Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Effortless IVF is a specialized fertility clinic and treatment brand that offers a simplified, low-cost alternative to traditional in vitro fertilization (IVF). Originally developed by reproductive endocrinologists Drs. Kevin and Kathleen Doody at CARE Fertility in Texas, the "effortless" protocol utilizes the FDA-approved INVOcell device for intravaginal culture (IVC). This method uses the patient's own body as a natural incubator, eliminating the need for expensive laboratory equipment and frequent monitoring, which reduces treatment costs by approximately 50% while maintaining comparable success rates. In November 2021, Effortless IVF was acquired by INVO Bioscience, the manufacturer of the INVOcell device, as part of a broader strategy to expand access to affordable fertility care through dedicated INVO Centers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Effortless IVF.